Joint marketing of CytoSorb® with B. Braun’s newest OMNI® blood purification platform will offer greater access of this advanced treatment of deadly inflammation to critically ill patients. MELSUNGEN, Germany and MONMOUTH JUNCTION, N.J., March 2, 2021 /PRNewswire/ — B. Braun Avitum AG, a leading manufacturer of medical devices and pharmaceutical products and services and CytoSorbents Corporation […]
A Month's-End Associated Press (AP) Photographic Celebration Of
Nouvelles officielles de Cooperation 2024
Organization, Facts & Figures
B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®
Newsroom
Leap by McKinsey Research Shows 50 Percent of Global Revenue Will
Memic Receives FDA Authorization for Hominis® Robot-Assisted
B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®
B. Braun Melsungen AG
B. Braun and CytoSorbents Announce Global Co-Marketing Agreement
B. Braun
